Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection.
Zarębska-Michaluk D, Jaroszewicz J, Parfieniuk-Kowerda A, Pawłowska M, Janczewska E, Berak H, Janocha-Litwin J, Klapaczyński J, Tomasiewicz K, Piekarska A, Krygier R, Citko J, Tronina O, Dobrowolska K, Flisiak R. Zarębska-Michaluk D, et al. Among authors: dobrowolska k. J Clin Med. 2022 Jan 13;11(2):389. doi: 10.3390/jcm11020389. J Clin Med. 2022. PMID: 35054088 Free PMC article.
Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance.
Flisiak R, Zarębska-Michaluk D, Rogalska M, Kryńska JA, Kowalska J, Dutkiewicz E, Dobrowolska K, Jaroszewicz J, Moniuszko-Malinowska A, Rorat M, Podlasin R, Tronina O, Rzymski P. Flisiak R, et al. Among authors: dobrowolska k. Pharmacol Rep. 2022 Dec;74(6):1279-1285. doi: 10.1007/s43440-022-00408-6. Epub 2022 Aug 24. Pharmacol Rep. 2022. PMID: 36001284 Free PMC article.
Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance.
Flisiak R, Zarębska-Michaluk D, Rogalska M, Kryńska JA, Kowalska J, Dutkiewicz E, Dobrowolska K, Jaroszewicz J, Moniuszko-Malinowska A, Rorat M, Podlasin R, Tronina O, Rzymski P. Flisiak R, et al. Among authors: dobrowolska k. Pharmacol Rep. 2022 Dec;74(6):1328. doi: 10.1007/s43440-022-00419-3. Pharmacol Rep. 2022. PMID: 36190677 Free PMC article. No abstract available.
Differences between the course of SARS-CoV-2 infections in the periods of the Delta and Omicron variant dominance in Poland.
Dobrowolska K, Brzdęk M, Zarębska-Michaluk D, Rzymski P, Rogalska M, Moniuszko-Malinowska A, Szymanek-Pasternak A, Jaroszewicz J, Dutkiewicz E, Kowalska J, Sikorska K, Flisiak R. Dobrowolska K, et al. Pol Arch Intern Med. 2023 May 23;133(5):16403. doi: 10.20452/pamw.16403. Epub 2023 Jan 5. Pol Arch Intern Med. 2023. PMID: 36602857 Free article.
Genotype 4 hepatitis C virus-a review of a diverse genotype.
Brzdęk M, Dobrowolska K, Flisiak R, Zarębska-Michaluk D. Brzdęk M, et al. Among authors: dobrowolska k. Adv Med Sci. 2023 Mar;68(1):54-59. doi: 10.1016/j.advms.2022.12.003. Epub 2023 Jan 12. Adv Med Sci. 2023. PMID: 36640687 Review.
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database.
Flisiak R, Rzymski P, Zarębska-Michaluk D, Ciechanowski P, Dobrowolska K, Rogalska M, Jaroszewicz J, Szymanek-Pasternak A, Rorat M, Kozielewicz D, Kowalska J, Dutkiewicz E, Sikorska K, Moniuszko-Malinowska A. Flisiak R, et al. Among authors: dobrowolska k. Viruses. 2023 Jan 3;15(1):149. doi: 10.3390/v15010149. Viruses. 2023. PMID: 36680188 Free PMC article.
Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings.
Dobrowolska K, Zarębska-Michaluk D, Brzdęk M, Rzymski P, Rogalska M, Moniuszko-Malinowska A, Kozielewicz D, Hawro M, Rorat M, Sikorska K, Jaroszewicz J, Kowalska J, Flisiak R. Dobrowolska K, et al. J Clin Med. 2023 Mar 19;12(6):2371. doi: 10.3390/jcm12062371. J Clin Med. 2023. PMID: 36983370 Free PMC article.
30 results